14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 85 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MAK.DE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Maternus-Kliniken Aktiengesellschaft stock upgraded from Sell Candidate to Hold/Accumulate after Friday trading session.
(Updated on May 17, 2024)

Hold candidate since May 17, 2024 PDF

The Maternus-Kliniken Aktiengesellschaft stock price gained 1.16% on the last trading day (Friday, 17th May 2024), rising from 1.73€ to 1.75€. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.74% from a day low at 1.72€ to a day high of 1.75€. The price has risen in 6 of the last 10 days but is still down by -0.57% for this period.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.45% during the next 3 months and, with a 90% probability hold a price between 1.15€ and 1.30€ at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MAK.DE Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, May 09, 2024, and so far it has risen 4.17%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Maternus-Kliniken Aktiengesellschaft stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at 1.88€. On a fall, the stock will find some support from the short-term average at 1.72€. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Maternus-Kliniken Aktiengesellschaft stock

Maternus-Kliniken Aktiengesellschaft finds support from accumulated volume at 1.73€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved 0.0300€ between high and low, or 1.74%. For the last week the stock has had daily average volatility of 0.83%.

Our recommended stop-loss: 1.67€ (-4.45%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (MAK.DE) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Maternus-Kliniken Aktiengesellschaft to open at 1.74€, and during the day (based on 14 day Average True Range), to move between 1.72€ and 1.78€, which gives a possible trading interval of +/-0.0343€ (+/-1.96%) up or down from last closing price. If Maternus-Kliniken Aktiengesellschaft takes out the full calculated possible swing range there will be an estimated 3.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 1.73€ (1.14%) than the resistance at 1.87€ (6.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Maternus-Kliniken Aktiengesellschaft stock A Buy?

Maternus-Kliniken Aktiengesellschaft holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.873 Hold/Accumulate Upgraded

Predicted Opening Price for Maternus-Kliniken Aktiengesellschaft of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
1.74€ ( 0.571%) 1.75€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MAK.DE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.77 1.14 %
R2 1.76 0.488 %
R1 1.75 0.0834 %
Current price: 1.75
Support S1 1.73 -1.23 %
S2 1.72 -1.63 %
S3 1.71 -2.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.02 15.43 %
R2 1.91 9.14 %
R1 1.87 6.86 %
Current price 1.75
Support S1 1.73 -1.14%
S2 1.70 -2.86%
S3 1.69 -3.43%

MAK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Aug 08, 2000 Aug 31, 2000 Aug 31, 2000 0.380€ 5.03%

FAQ

What is the symbol for Maternus-Kliniken Aktiengesellschaft Stock and on which exchange is it traded?
The symbol for Maternus-Kliniken Aktiengesellschaft is MAK.DE and it is traded on the GER (Deutsche Börse XETRA).

Should I buy or sell Maternus-Kliniken Aktiengesellschaft Stock?
Maternus-Kliniken Aktiengesellschaft holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Maternus-Kliniken Aktiengesellschaft Stock?
Maternus-Kliniken Aktiengesellschaft Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Maternus-Kliniken Aktiengesellschaft Stock.

What's the current price of Maternus-Kliniken Aktiengesellschaft Stock?
As of the end of day on the May 17, 2024, the price of an Maternus-Kliniken Aktiengesellschaft (MAK.DE) share was 1.75€.

What is the 52-week high and low for Maternus-Kliniken Aktiengesellschaft Stock?
The 52-week high for Maternus-Kliniken Aktiengesellschaft Stock is 4.70€ and the 52-week low is 1.35€.

What is the market capitalization of Maternus-Kliniken Aktiengesellschaft Stock?
As of the May 17, 2024, the market capitalization of Maternus-Kliniken Aktiengesellschaft is 36.698M.

When is the next earnings date for Maternus-Kliniken Aktiengesellschaft?
The upcoming earnings date for Maternus-Kliniken Aktiengesellschaft is Sep 13, 2024.
Click to get the best stock tips daily for free!

About Maternus-Kliniken Aktiengesellschaft

Maternus-Kliniken Aktiengesellschaft Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company... MAK.DE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT